Roundtable: Legalizing psychedelics in California

Psychedelic legalization movements in California are gaining momentum as advocates emphasize their clinical potential for mental health. Veterans are prominent advocates, sharing experiences of using substances like ibogaine outside the country to treat combat trauma and PTSD when conventional Western therapies have failed. These accounts fuel calls for broader access and research within the United States. Legislation such as Senate Bill 519 seeks to expand access to psychedelic therapies. Debates persist regarding whether these initiatives should focus exclusively on clinical access for specific conditions or broader decriminalization for personal use. While proponents argue that clinical research and personal access can exist side by side, ongoing legislative discussions underscore the tension between harm reduction goals and concerns over widespread, unregulated use.